About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 236539, 12 pages
http://dx.doi.org/10.1155/2012/236539
Research Article

Sarcandra glabra Extract Reduces the Susceptibility and Severity of Influenza in Restraint-Stressed Mice

1Department of Medicine, Institute of Traditional Chinese Medicine and Natural Products, Jinan University, Guangzhou 510632, China
2Institute of Biomedical and Health Engineering, Translational Medicine Research and Development Center, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China
3State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
4Pharmacology Laboratory of Traditional Chinese Medicine, Guangdong Provincial Institute of Traditional Chinese Medicine, Guangzhou 510095, China

Received 5 July 2012; Revised 12 September 2012; Accepted 20 September 2012

Academic Editor: Seong-Gyu Ko

Copyright © 2012 Hui-Juan Cao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, Clinical Management of Human Infection with New Influenza A (H1N1) Virus: Initial Guidance, WHO, Geneva, Switzerland, 2009, http://www.who.int/.
  2. M. B. Rothberg and S. D. Haessler, “Complications of seasonal and pandemic influenza,” Critical Care Medicine, vol. 38, no. 4, pp. e91–e97, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Hayden, “Developing new antiviral agents for influenza treatment: what does the future hold?” Clinical Infectious Diseases, vol. 48, no. 1, supplement, pp. S3–S13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. W. Paul Glezen, “Prevention and treatment of seasonal influenza,” The New England Journal of Medicine, vol. 359, no. 24, pp. 2579–2585, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. The State of Pharmacopoeia Commission of People's Republic of China, Pharmacopoeia of People's Republic of China, Chemical Industry Press, Beijing, China, 2005.
  6. J. Dushoff, J. B. Plotkin, C. Viboud, D. J. D. Earn, and L. Simonsen, “Mortality due to influenza in the United States—an annualized regression approach using multiple-cause mortality data,” American Journal of Epidemiology, vol. 163, no. 2, pp. 181–187, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. K. F. Cheng and P. C. Leung, “What happened in China during the 1918 influenza pandemic?” International Journal of Infectious Diseases, vol. 11, no. 4, pp. 360–364, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. D. M. Fleming and A. J. Elliot, “The impact of influenza on the health and health care utilisation of elderly people,” Vaccine, vol. 23, no. 1, pp. S1–S9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Glaser and J. K. Kiecolt-Glaser, “Science and society—stress-induced immune dysfunction: implications for health,” Nature Reviews Immunology, vol. 5, no. 3, pp. 243–251, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. R. R. He, M. Wang, C. Z. Wang et al., “Protective effect of apple polyphenols against stress-provoked influenza viral infection in restraint mice,” Journal of Agricultural and Food Chemistry, vol. 59, no. 8, pp. 3730–3737, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. R. R. He, X. S. Yao, H. Y. Li et al., “The anti-stress effects of Sarcandra glabra extract on restraint-evoked immunocompromise,” Biological and Pharmaceutical Bulletin, vol. 32, no. 2, pp. 247–252, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. Y.-M. Pan, Z.-H. Yao, D. Yi, Z. Yi, D. Ying-hui, and Y. Xin-sheng, “Content determination of rosmarinic acid and isofraxidin in Sarcandra glabra extract and preparations by HPLC –UVD,” Journal of Shenyang Pharmaceutical University, vol. 27, no. 6, pp. 457–461, 2010.
  13. S. T. Mayne, “Antioxidant nutrients and chronic disease: use of biomarkers of exposure and oxidative stress status in epidemiologic research,” Journal of Nutrition, vol. 133, no. 3, pp. 933S–940S, 2003. View at Scopus
  14. S. Q. Wu, M. Oteroc, F. M. Ungera et al., “Anti-inflammatory activity of an ethanolic Caesalpinia sappan extract in human chondrocytes and macrophages,” Journal of Ethnopharmacology, vol. 138, no. 2, pp. 364–372, 2011. View at Publisher · View at Google Scholar
  15. N.-S. Zhong, Y.-M. Li, Z.-F. Yang et al., “Chinese guidelines for diagnosis and treatment of influenza (2011),” Journal of Thoracic Disease, vol. 3, no. 4, pp. 274–289, 2011.
  16. C. Z. Wang, P. Li, and C. S. Yuan, “Traditional chinese herbal therapy as a treatment option for H1N1 influenza,” Annals of Internal Medicine, vol. 156, no. 2, pp. 166–167, 2012. View at Scopus
  17. X. Wang, W. Jia, A. Zhao, and X. Wang, “Anti-influenza agents from plants and traditional chinese medicine,” Phytotherapy Research, vol. 20, no. 5, pp. 335–341, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Fukuyama and Y. Kawaoka, “The pathogenesis of influenza virus infections: the contributions of virus and host factors,” Current Opinion in Immunology, vol. 23, no. 4, pp. 481–486, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. J. A. Belser, D. A. Wadford, C. Pappas et al., “Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice,” Journal of Virology, vol. 84, no. 9, pp. 4194–4203, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. D. de Jong, C. P. Simmons, T. T. Thanh et al., “Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia,” Nature Medicine, vol. 12, no. 10, pp. 1203–1207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Malhotra and R. B. Sim, “Collectins and viral infection,” Trends in Microbiology, vol. 3, no. 6, pp. 240–244, 1995. View at Publisher · View at Google Scholar · View at Scopus
  22. K. L. Hartshorn, M. R. White, V. Shepherd, K. Reid, J. G. Jensenius, and E. C. Crouch, “Mechanisms of anti-influenza activity of surfactant proteins A and D: comparison with serum collectins,” The American Journal of Physiology, vol. 273, no. 6, pp. L1156–L1166, 1997. View at Scopus
  23. S. Hawgood, C. Brown, J. Edmondson et al., “Pulmonary collectins modulate strain-specific influenza A virus infection and host responses,” Journal of Virology, vol. 78, no. 16, pp. 8565–8572, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. M. LeVine, J. A. Whitsett, K. L. Hartshorn, E. C. Crouch, and T. R. Korfhagen, “Surfactant protein D enhances clearance of influenza A virus from the lung in vivo,” Journal of Immunology, vol. 167, no. 10, pp. 5868–5873, 2001. View at Scopus
  25. A. M. LeVine, K. E. Kurak, M. D. Bruno, J. M. Stark, J. A. Whitsett, and T. R. Korfhagen, “Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection,” The American Journal of Respiratory Cell and Molecular Biology, vol. 19, no. 4, pp. 700–708, 1998. View at Scopus
  26. V. Davé, T. Childs, Y. Xu et al., “Calcineurin/Nfat signaling is required for perinatal lung maturation and function,” Journal of Clinical Investigation, vol. 116, no. 10, pp. 2597–2609, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Yoeli-Lerner, G. K. Yiu, I. Rabinovitz, P. Erhardt, S. Jauliac, and A. Toker, “Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT,” Molecular Cell, vol. 20, no. 4, pp. 539–550, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Ito, H. Okumura, N. Tsukue, T. Kobayashi, K. Honda, and K. Sekizawa, “Effect of diesel exhaust particles on mRNA expression of viral and bacterial receptors in rat lung epithelial L2 cells,” Toxicology Letters, vol. 165, no. 1, pp. 66–70, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. L. D. Martin, T. M. Krunkosky, J. A. Voynow, and K. B. Adler, “The role of reactive oxygen and nitrogen species in airway epithelial gene expression,” Environmental Health Perspectives, vol. 106, no. 5, pp. 1197–1203, 1998. View at Scopus
  30. H. Takizawa, S. Abe, T. Ohtoshi et al., “Diesel exhaust particles up-regulate expression of intercellular adhesion molecule-1 (ICAM-1) in human bronchial epithelial cells,” Clinical and Experimental Immunology, vol. 120, no. 2, pp. 356–362, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Takeda and S. Akira, “Toll-like receptors in innate immunity,” International Immunology, vol. 17, no. 1, pp. 1–14, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. A. R. Everitt, S. Clare, T. Pertel et al., “IFITM3 restricts the morbidity and mortality associated with influenza,” Nature, vol. 484, no. 7395, pp. 519–523, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. V. Swarup, J. Ghosh, S. Ghosh, A. Saxena, and A. Basu, “Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis,” Antimicrobial Agents and Chemotherapy, vol. 51, no. 9, pp. 3367–3370, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. G. D. Gamaro, E. Suyenaga, M. Borsoi, J. Lermen, P. Pereira, and P. Ardenghi, “Effect of rosmarinic and caffeic acids on inflammatory and nociception process in rats,” ISRN Pharmacology, vol. 2011, Article ID 451682, 6 pages, 2011. View at Publisher · View at Google Scholar
  35. H. J. Luo, J. Z. Wang, J. F. Chen, and K. Zou, “Docking study on chlorogenic acid as a potential H5N1 influenza A virus neuraminidase inhibitor,” Medicinal Chemistry Research, vol. 20, no. 5, pp. 554–557, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. K. Ikeda, H. Tsujimoto, and M. Uozaki, “Inhibition multiplication of herpes simplex virus by caffeic acid,” International Journal of Molecular Medicine, vol. 28, no. 4, pp. 595–598, 2011.
  37. F. Wang, S. T. Yuan, and D. N. Zhu, “Active components of antitumor fraction from Sarcandra glabra,” Chinese Journal of Natural Medicines, vol. 5, no. 3, pp. 174–178, 2007. View at Scopus
  38. X. H. Xiao, Z. N. Guo, J. Deng, and G. Li, “Separation and purification of isofraxidin from Sarcandra glabra by microwave-assisted extraction coupled with high-speed counter-current chromatography,” Separation and Purification Technology, vol. 68, no. 2, pp. 250–254, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Geiler, M. Michaelis, P. Naczk et al., “N-acetyl-l-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus,” Biochemical Pharmacology, vol. 79, no. 3, pp. 413–420, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Won, Y. G. Hur, E. M. Hur et al., “Rosmarinic acid inhibits TCR-induced T cell activation and proliferation in an Lck-dependent manner,” European Journal of Immunology, vol. 33, no. 4, pp. 870–879, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. X. Chu, X. X. Ci, J. He et al., “Effects of a natural prolyl oligopeptidase inhibitor, rosmarinic acid, on lipopolysaccharide-induced acute lung injury in mice,” Molecules, vol. 17, no. 3, pp. 3586–3598, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Psotová, M. Kolář, J. Soušek, Z. Švagera, J. Vičar, and J. Ulrichová, “Biological activities of Prunella vulgaris extract,” Phytotherapy Research, vol. 17, no. 9, pp. 1082–1087, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Huang, C. Hauck, M. Y. Yum et al., “Rosmarinic acid in Prunella vulgaris ethanol extract inhibits lipopolysaccharide-Lnduced prostaglandin E2 and nitric oxide in RAW 264.7 mouse macrophages,” Journal of Agricultural and Food Chemistry, vol. 57, no. 22, pp. 10579–10589, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Widegren, M. Andersson, P. Borgeat, L. Flamand, S. Johnston, and L. Greiff, “LTB4 increases nasal neutrophil activity and conditions neutrophils to exert antiviral effects,” Respiratory Medicine, vol. 105, no. 7, pp. 997–1006, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. M. A. Carey, J. A. Bradbury, J. M. Seubert, R. Langenbach, D. C. Zeldin, and D. R. Germolec, “Contrasting effects of cyclooxygenase-1 (COX-1) and COX-2 deficiency on the host response to influenza A viral infection,” Journal of Immunology, vol. 175, no. 10, pp. 6878–6884, 2005. View at Scopus
  46. H. Y. Li, R. R. He, T. Liang, W. C. Ye, X. S. Yao, and H. Kurihara, “Effect of Sarcandra glabra (Thunb) Nakai extract on mice model of immunological hepatitis and acute inflammation,” Zhongguo Yaolixue Tongbao, vol. 24, no. 2, pp. 244–250, 2008. View at Scopus